Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic control

Technology

Inhibition Of Irak4 By Microbial Trimethylamine Blunts Metabolic Inflammation And Ameliorates Glycemic Control

By Nature

Globally, diabetes affects 529 million individuals1, claiming 1.6 million lives per year according to the World Health Organization. IR is a multifactorial condition and is now increasingly common owing to, among other factors, the increase in preval ...Read more